Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stone Three has developed commercialized digital health platforms that enable virtual consults with computer-assisted diagnostic solutions, particularly focused on cardiovascular disease. Their flagship product, TeleSensi™, allows real-time streaming of heart/lung sounds to remote providers during tele-consultations. The company leverages machine learning to enhance diagnosis accuracy and workflow integration. They are expanding into North America’s tele-auscultation market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stone Three.